On July 23, 2026, a trial update was recorded for insulin glargine in the study titled "Changing the Natural History of Type 2 Diabetes" (the "CHANGE" Study), registered as NCT05040087.
The trial's current status is listed as active, not recruiting. This means enrollment is closed but the study is ongoing. The trial phase is listed as not applicable (NA).
No results, efficacy data, or safety findings were included in this update. The event data reflects only the trial's administrative status as of the date reported.
Insulin glargine remains an approved compound. This update pertains solely to the status of this specific registered clinical trial and does not indicate any change in the drug's approval status or new safety information.
For more background on insulin glargine, readers can consult the compound overview.